Clinical trial
Phase 3 Study of BK1310 Intramuscular Injection in Healthy Infants
NCT03188692 is registered in ClinicalTrials.gov with Tanabe Pharma Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 3 Study of BK1310 Intramuscular Injection in Healthy Infants
- Lead sponsor
- Tanabe Pharma Corporation
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 23, 2017
- Completion date
- August 9, 2018
- Enrollment
- 33 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
immunization